Genomic Expression

Executive Summary

Genomic Expression is a Danish biotechnology company developing the proprietary OneRNA® platform for full transcriptome analysis, with an initial focus on oncology. The platform aims to personalize cancer treatment through drug repurposing and the design of novel RNA therapeutics. Founded in 2015, the company operates in the diagnostics space but is transitioning toward therapeutics. While the platform holds promise for both disease detection and therapy development, the company is private and has not disclosed funding or clinical milestones publicly. The technology addresses the growing demand for precision medicine, but progress remains unvalidated by major partnerships or regulatory approvals.

Upcoming Catalysts (preview)

• Q2 2026Initial Clinical Data from Oncology Study30% success
• Q4 2026Partnership with Pharmaceutical Company25% success
• Q3 2026Series A or B Funding Round Announcement40% success